SCHEMBL23892004

SCHEMBL23892004

FC(F)(F)c1ccc(C2=NCCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 9/20 0.50
CHRNA3 P32297 9/20 0.50
NISCH Q9Y2I1 1/20 0.47
KIF11 P52732 4/20 0.45
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
THRB P10828 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.41
PTGS2 P35354 2/20 0.39
PTGS1 P23219 1/20 0.39
TNKS O95271 1/20 0.38
PARP1 P09874 1/20 0.38
WNT3A P56704 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4026905 0.81 CHRNB4 (0.47) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL28303398 0.81 CHRNB4 (0.50) CHRNB4CHRNA3NISCHKIF11ALDH1A1
SCHEMBL9583820 0.79 CHRNB4 (0.57) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL24414772 0.78 CHRNB4 (0.55) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL27584798 0.75 ALDH1A1 (0.60) CHRNB4CHRNA3NISCHALDH1A1CYP1A2
SCHEMBL15665457 0.74 CHRNB4 (0.55) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL4693339 0.74 CHRNB4 (0.55) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL27928338 0.74 CHRNB4 (0.55) CHRNB4CHRNA3NISCHALDH1A1CYP1A2
SCHEMBL3574404 0.74 CHRNB4 (0.55) CHRNB4CHRNA3ALDH1A1CYP1A2THRB
SCHEMBL2045328 0.74 CHRNB4 (0.57) CHRNB4CHRNA3ALDH1A1CYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177611-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2021-10-06 EP disclosed